Takeda Achieves Major Milestone With Holistic Narcolepsy Drug Approval
Takeda secured FDA approval for ORZEYFUL, a first-in-class oral orexin treatment for adults with narcolepsy type 1.
Takeda just got permission to sell a brand-new medicine for a sleep disorder that keeps people awake when they don't want to be. This is a win because it's the first medicine of its kind, and doctors can now offer it to patients who need help.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.